Private company

Allied Corp.

In its 2024 annual report the company says: “Allied Corp. is an international cannabis company with its main production center in Colombia, is one of the few companies that has exported from Colombia internationally, and among the first company to export commercial cannabis flower from Colombia.”4 It is headquartered in Kelowna, Canada.1

Last updated Oct 21, 2026.

Overview

$96.2KRevenue, fiscal 20242
-$4.0MNet income, fiscal 20242
  • IndustryRetail-Catalog & Mail-Order Houses1
  • HeadquartersKelowna, Canada1
  • Incorporated inNV3
  • Business addressSuite 200-460 Doyle Ave, Kelowna, A1 V1Y Oc23
  • Filer category, Emerging growth company3
  • Legal formCorporation

Allied Corp. is an international cannabis company with its main production center in Colombia, is one of the few companies that has exported from Colombia internationally, and among the first company to export commercial cannabis flower from Colombia. By leveraging the Colombian advantages and its Canadian cannabis cultivation expertise, Allied offers consistent supply of premium cannabis product at scale and attractive prices, while meeting high quality standards, thus significantly de-risking its partners supply chain.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2024

-336.0%Gross margin2
-4134.1%Operating margin2
-4134.1%Net margin2
33.4%Revenue growth, 20242
-$2.0MFree cash flow2

Where the money goes

Where each dollar of revenue went, fiscal 2024

  • Cost of revenue100¢$419.3K

Out of $96.2K in revenue.2 The company lost money this year.

Financial statements

Revenue5672$96.2K in 2024
0$50.0K$100.0K$150.0K$200.0K2020: $0$020202021: $16.0K$16.0K20212022: $165.6K$165.6K2022+933%2023: $72.1K$72.1K2023−56%2024: $96.2K$96.2K2024+33%
Gross profit672-$323.1K in 2024−48% since 2021
-$1.5M-$1.0M-$500.0K0$500.0K2021: -$625.5K-$625.5K20212022: $74.1K$74.1K20222023: -$1.5M-$1.5M20232024: -$323.1K-$323.1K2024−78%
Operating income58672-$4.0M in 2024+206% since 2019
-$15.0M-$10.0M-$5.0M02019: -$1.3M-$1.3M20192020: -$3.6M-$3.6M2020+176%2021: -$7.5M-$7.5M2021+108%2022: -$14.8M-$14.8M2022+98%2023: -$7.8M-$7.8M2023−47%2024: -$4.0M-$4.0M2024−49%
Net income91058672-$4.0M in 2024+19535% since 2017
-$20.0M-$15.0M-$10.0M-$5.0M02017: -$20.3K-$20.3K20172018: -$19.3K-$19.3K2018−5%2019: -$1.3M-$1.3M2019+6656%2020: -$6.6M-$6.6M2020+408%2021: -$11.5M-$11.5M2021+74%2022: -$15.5M-$15.5M2022+35%2023: -$10.7M-$10.7M2023−31%2024: -$4.0M-$4.0M2024−63%
Fiscal year20172018201920202021202220232024
Revenue$05$16.0K6$165.6K7$72.1K2$96.2K2
Cost of revenue$641.5K6$91.5K7$1.5M2$419.3K2
Gross profit-$625.5K6$74.1K7-$1.5M2-$323.1K2
Research and development$26.6K5$05$06$12.1K7$07
Operating expenses$14.8M7$6.4M2$3.7M2
Operating income-$1.3M5-$3.6M8-$7.5M6-$14.8M7-$7.8M2-$4.0M2
Interest$05$148.2K8$459.2K6$219.3K7$385.5K7
Income tax$05$08$06$07$02$02
Net income-$20.3K9-$19.3K10-$1.3M5-$6.6M8-$11.5M6-$15.5M7-$10.7M2-$4.0M2
Earnings per share (diluted)-$0.112-$0.042
Shares (weighted, diluted)96.8M shares2105.6M shares2

Compare Allied Corp. with another company

What it owns

What Allied Corp. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.8M2 Aug 31, 2024$1.8M2 Aug 31, 2023−1.4%
Accumulated depreciation$591.8K2 Aug 31, 2024$418.4K2 Aug 31, 2023+41.4%
Property and equipment, net$1.2M2 Aug 31, 2024$1.4M2 Aug 31, 2023−14.0%
Operating-lease assets (leased space)$131.9K2 Aug 31, 2024$109.3K2 Aug 31, 2023+20.6%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$209.7K7 Aug 31, 2023$96.0K7 Aug 31, 2022+118.4%

Intangibles and goodwill

ItemLatestA year beforeChange
Accumulated amortization-$1.1M7 Aug 31, 2023
Finite-lived intangibles, net$30.6K2 Aug 31, 2024$40.3K2 Aug 31, 2023−24.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$261.0K2 Aug 31, 2024$107.5K2 Aug 31, 2023+142.8%
Work in process$132.5K2 Aug 31, 2024$80.1K2 Aug 31, 2023+65.4%
Finished goods$128.5K2 Aug 31, 2024$27.4K2 Aug 31, 2023+368.7%

Properties, in its own words

Bucamaranga, Colombia

The Company’s 100% owned subsidiary, Allied Colombia, S.A.S., has secured vast agricultural land extension in Bucamaranga, a key production farming region of Colombia. Both areas have the benefit of having 12 hours of sunlight year-round, temperatures oscillating between 20-30 degrees celsius, with constant humidity. This environment and situation ideal to growing cannabis at low cost. The Ibague land has an area of 1,400 hectares (about 3,450 acres), all with water rights, an electrical substation, and great paved access to the property. This is situated in close proximity to the free trade zone. The Company currently has a lease arrangement for 5 hectares and a cost of $1,600 per month with an option to purchase. Further, the Company has the ability to expand its leased land footprint to the adjacent 24-hectare property.

The rest of Item 2

Kelowna, British Columbia, Canada

We have office space available at 200-460 Doyle Ave, Kelowna, British Columbia, V1Y OC2, Canada. At that location Allied leases an office space within which executives of the Company can host virtual meetings via zoom, host team days and operate general corporate affairs. There is working space for Allied corporate personnel and several meeting rooms that can be rented from $10.00 per hour to a large hall that can be rented for $50.00 per hour.

Item 2 of the 10-K filed Dec 16, 2024.4

Leadership

Who has led Allied Corp., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Calum Hughes2019

Chief operating officer

  1. Paul James Bullock2019
20202025
Board members and other officers (5)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerMichael Moses named Aug 9, 202419
  • Executive Officer, DirectorJim Smeeding named Nov 15, 2021 to Oct 5, 202320
  • Executive OfficerRyan Maarschalk named Nov 15, 2021 to Oct 5, 202320
  • DirectorJames Smeeding named Aug 9, 202419
  • DirectorSantiago Ribero named Oct 5, 202320

Former names

  • COSMO VENTURES INCMay 28, 2013 to Jul 2, 20193

Timeline

  1. Feb 5, 20258-K Executive or director change21
  2. Jan 22, 20258-K Other events22
  3. Nov 18, 20248-K Other events23
  4. Oct 15, 20248-K Entered a material agreement24
  5. Sep 24, 20248-K Other events25
  6. Sep 13, 20248-K Executive or director change26
  7. Jul 1, 20248-K Other events27
  8. Mar 27, 20248-K Executive or director change; Other events28
  9. Dec 5, 20238-K Entered a material agreement29
  10. Dec 5, 20238-K Entered a material agreement30
  11. Dec 5, 20238-K Entered a material agreement31
  12. Jul 27, 20228-K Change of auditor32
  13. Sep 27, 2019New chief executive Calum Hughes becomes CEO15

Filings

64 filings to the SEC since October 2021: 7 annual reports, 12 quarterly reports, 14 major events, 1 insider forms, 5 private raises, 25 other. The latest 20:

  1. Feb 11, 202515-12G EDGAR
  2. Feb 5, 20258-K EDGAR
  3. Feb 3, 202525 EDGAR
  4. Jan 22, 20258-K EDGAR
  5. Jan 14, 202510-Q EDGAR
  6. Dec 18, 202410-K/A EDGAR
  7. Dec 16, 202410-K EDGAR
  8. Nov 29, 2024NT 10-K EDGAR
  9. Nov 18, 20248-K EDGAR
  10. Oct 15, 20248-K EDGAR
  11. Sep 24, 20248-K EDGAR
  12. Sep 13, 20248-K EDGAR
  13. Aug 9, 2024D/A EDGAR
  14. Aug 8, 2024D EDGAR
  15. Jul 18, 202410-Q EDGAR
  16. Jul 16, 2024NT 10-Q EDGAR
  17. Jul 1, 20248-K EDGAR
  18. Apr 19, 202410-Q EDGAR
  19. Apr 15, 2024NT 10-Q EDGAR
  20. Mar 27, 20248-K EDGAR

The 64 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Apr 27, 2023Robinson James GeorgeDirectorBuy40,000$0.47$18.8KForm 4
Apr 25, 2023Robinson James GeorgeDirectorBuy40,000$0.45$18.0KForm 4

From Forms 4 filed with the SEC.

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Money received by year$5.9M 2018–2024
Money received by yearMoney received by year, 2018–2024: $5.9M in all. Private raises (Form D) $5.9M.$0$1M$2M$3M$4M2018 · Private raises (Form D): $1.5M201820202021 · Private raises (Form D): $3.2M20222023 · Private raises (Form D): $761.3K2024 · Private raises (Form D): $500.0K2024
Figures by year
YearPrivate raises (Form D)Total
2024$500.0K$500.0K
2023$761.3K$761.3K
2021$3.2M$3.2M
2018$1.5M$1.5M

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

  1. Apr 10, 2024Raised $500,000 in a private offering of equity19 Form D: 1 investor so far Form D
  2. Jul 6, 2023Raised $761,328 in a private offering of equity20 Form D: $1.5 million offered in all Form D
  3. Jul 16, 2021Raised $3.2 million in a private offering of equity33 Form D: $5.2 million offered in all Form D
  4. Jul 20, 2018Raised $1.5 million in a private offering of equity34 Form D: $1.5 million offered in all Form D

SEC filer profile

How Allied Corp. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARAllied Corp.1
  • CIK0001575295
  • Employer ID (EIN)33-12271731
  • Filer status<br>emerging growth company1
  • Incorporated inNevada1
  • Fiscal year endsAugust 311
  • Industry code (SIC)5961 Retail-Catalog & Mail-Order Houses1
  • SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
  • Business addressSuite 200-460 Doyle Ave, Kelowna, A1 V1Y OC21
  • Phone877-255-43371
  • Shares outstanding115,495,384 as of Dec 16, 20242
  • Public float$10.7M as of Aug 31, 20242
  • On EDGAR sinceMay 28, 20131
  • Filings164 in all: 10-Q (33), 8-K (28), NT 10-Q (17), 10-K (11), D (11), UPLOAD (10), NT 10-K (7), SC 13G (5)1
    All 33 form types

    10-K/A (4), 3 (4), CORRESP (4), 10-Q/A (3), 8-K/A (3), S-1/A (3), 1-A (2), 1-A/A (2), 1-A-W (1), 10-KT (1), 15-12G (1), 25 (1), 4 (1), 424B3 (1), 8-A12G (1), 8-A12G/A (1), D/A (1), DEF 14A (1), DEFR14A (1), EFFECT (1), NT 10-K/A (1), NTN 10K (1), QUALIF (1), S-1 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Dec 16, 2024
    Quarterly report (10-Q) Jan 14, 2025
    Proxy statement (DEF 14A) Jul 2, 2019
    Latest 8-K (8-K) Feb 5, 2025

Risk factors and legal proceedings

The risks Allied Corp. names in Item 1A of its 10-K filed Dec 16, 2024: 60 risks under these headings, as written.4

  • Risks Related to Our Operations
  • We have a history of operating losses and our management has concluded that factors raise substantial doubt about our ability to continue as a going concern and our auditor has included an explanatory paragraph relating to its ability to continue as a going concern in their audit report for the years ended August 31, 2024 and 2023.
  • We may need additional capital in the future in order to continue our operations.
  • The occurrence or resurgence of global or regional health events, such as the COVID-19 outbreak or similar pandemics could adversely affect our operations.
  • We launched our cannabis products in 2019 in an initially limited fashion and as a company, we have limited sales and marketing experience.
  • Recent and future acquisitions and strategic investments could be difficult to integrate, divert the attention of key management personnel, disrupt our business, dilute shareholder value, and harm our results of operations and financial condition.
  • Certain conditions or events could disrupt the Company’s supply chains, disrupt operations, and increase operating expenses.
  • We will depend on a limited number of customers for the majority of our revenue, and the loss of any one of these customers could substantially reduce our revenue and impact our liquidity.
  • Demand for cannabis and derivative products could be adversely affected and significantly influenced by scientific research or findings, regulatory proceedings, litigation, media attention or other research findings.
  • Damage to the Company’s reputation can be the result of the actual or perceived occurrence of any number of events, and could include any negative publicity, whether such publicity is accurate or not.
  • We are subject to the inherent risks involved with product recalls.
  • The Company’s products could have unknown side effects.
The other 49 risks
  • Research regarding the medical benefits, viability, safety, efficacy, use and social acceptance of cannabis remains in early stages.
  • The seasonal trends in our business create variability in our financial and operating results.
  • The Company may not be able to maintain effective quality control systems.
  • Energy prices and supply may be subject to change or curtailment due to new laws or regulations, imposition of new taxes or tariffs, interruptions in production by suppliers, imposition of restrictions on energy supply by government, worldwide price levels and market conditions.
  • There are risks associated with the regulatory regime and permitting requirements of our operations.
  • The cannabinoid industry faces strong opposition and may face similar opposition in other jurisdictions in which we operate.
  • We are subject to the risks inherent in an agricultural business.
  • Our operations could be materially and adversely affected if the supply of cannabis seeds is ceased or delayed and we do not find replacement suppliers and obtain all necessary authorizations.
  • The legalization of adult-use, recreational cannabis may reduce sales of medical cannabis.
  • The Company is reliant on third party transportation services and importation services to deliver its products to customers.
  • The Company is dependent on suppliers to supply equipment, parts and components for the operation of its business.
  • We may not be able to establish and maintain bank accounts in certain countries.
  • The Company may be subject to cyber-security and privacy risks that could disrupt its operations and expose the Company to financial losses, contractual losses, liability, reputational damage and additional expense.
  • The Company may incur significant costs to defend its intellectual property and other proprietary rights.
  • Risks Related to Operations in Colombia
  • We are reliant on certain licenses and authorizations to operate in Colombia.
  • Restrictions or regulations concerning changes in corporate structure may discourage transactions that otherwise could involve payment of a premium over prevailing market process for our securities.
  • Our cultivation operations are located in Colombia, which may make it more difficult for investors to understand and predict how changing market and economic conditions will affect our financial results.
  • Economic and political conditions in Colombia may have an adverse effect on our financial condition and results of operations.
  • Colombia is experiencing substantial inflation resulting in the Company’s costs in the Colombian peso increasing significantly.
  • Colombia has experienced and continues to experience internal security issues that have had or could have a negative effect on the Colombian economy and our financial condition.
  • Political and economic instability in the region may affect the Colombian economy and, consequently, our results of operations and financial condition.
  • Any additional taxes resulting from changes to tax regulations or the interpretation thereof in Colombia or other countries where we operate, could adversely affect our consolidated results.
  • Risks Related to Our Regulatory Framework
  • United States Federal regulation and enforcement may adversely affect the implementation of medical Cannabis and/or Cannabis adult use laws and regulations may negatively impact our revenues and profits.
  • There are conflicts in the United States between Federal and State regulations related to marijuana.
  • Any failure on our part to comply with applicable regulations could prevent us from being able to carry on our business, and there may be additional costs associated with any such failure.
  • The legal cannabis market is a relatively new industry. As a result, the size of our target market is difficult to quantify, and investors will be reliant on their own estimates on the accuracy of market data.
  • We could be adversely affected by violations of the U.S. Foreign Corrupt Practices Act and similar international anti-bribery and anti-kickback laws with respect to our activities outside the United States.
  • Risks Related to Financials and Accounting
  • Assumptions, estimates and judgments related to critical accounting matters could significantly affect our reported financial results or financial condition.
  • There are tax risks the Company may be subject to in carrying on business in multiple jurisdictions.
  • Restrictions on Deduction of Certain Expenses for U.S. Federal Income Tax Purposes
  • Failure to develop our internal controls over financial reporting as we grow could have an adverse effect on our operations.
  • Risks Related to Our Common Shares
  • We will need, but may be unable to, obtain additional funding on satisfactory terms, which could dilute our shareholders or impose burdensome financial restrictions on our business.
  • Holders of our Common Shares are subject to dilution resulting from the issuance of equity-based compensation by us.
  • Ownership of our Common Shares may be considered unlawful in some jurisdictions and holders of our Common Shares may consequently be subject to liability in such jurisdictions.
  • Our executive officers and directors and their respective affiliates may continue to exercise significant control over our Company, which will limit your ability to influence corporate matters and could delay or prevent a change in corporate control.
  • The Company’s directors and officers may have conflicts of interest in conducting their duties.
  • The regulated nature of our business may impede or discourage a takeover, which could reduce the market price of our Common Shares.
  • We do not intend to pay dividends on our Common Shares in the near future, and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our Common Shares.
  • Future issuances of debt securities, which would rank senior to our Common Shares upon our bankruptcy or liquidation, and future issuances of preferred stock, which could rank senior to our Common Shares for the purposes of dividends and liquidating distributions, may adversely affect the level of return you may be able to achieve from an investment in our Common Shares.
  • General Risk Factors
  • The Company is at this point and is in a protracted legal proceeding and may in the future become involved in legal proceedings from time to time, which could adversely affect the Company.
  • The Company’s success will depend, in part, on its ability to continue to enhance its product and service offerings to respond to technological and regulatory changes and emerging industry standards and practices.
  • We are dependent upon our management and key employees, and the loss of any member of our management team or key employees could have a material adverse effect on our operations.
  • Our inability to retain and acquire skilled personnel could impair our business and operations.
  • We will need to grow the size of our organization, and we may experience difficulties in managing any growth we may achieve.
  • If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about us, our share price and trading volume could decline.
  • We expect to incur significant ongoing costs and obligations related to our investment in infrastructure, growth, regulatory compliance and operations.
  • There is no assurance that the Company’s will have insurance coverage sufficient to cover all claims to which the Company may become subject.
  • We may be unable to implement our business strategy, which could have negative financial and reputational effects on our business.
  • The Company could be subject to a security breach that could result in significant damage or theft of products and equipment.

Legal proceedings

Other than the legal proceedings in Nevada involving retrieving our asset from the bankruptcy proceedings of another company as described under “Business”, we are not aware of any legal proceedings contemplated by any governmental authority or any other party involving us or our properties.

As of the date of this report, no director, officer or affiliate is (i) a party adverse to us in any legal proceeding, or (ii) has an adverse interest to us in any legal proceedings. We are not aware of any other legal proceedings pending or that have been threatened against us or our properties.

From time to time the Company may be named in claims arising in the ordinary course of business. Currently, no legal proceedings or claims, other than those disclosed above, are pending against or involve the Company that, in the opinion of management, could reasonably be expected to have a material adverse effect on its business and financial condition. The company doesn’t have any material updates on this matter beyond what is stated.

The opening of Item 3, Legal Proceedings.4

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
    SEC EDGAROther events
  23. 23
    SEC EDGAROther events
  24. 24
  25. 25
    SEC EDGAROther events
  26. 26
  27. 27
    SEC EDGAROther events
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34